CLL Testing & Imaging Archives

January 5, 2022

Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: IGHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

As new and better treatments are developed to treat Chronic Lymphocytic Leukemia, and Small Lymphocytic Lymphoma (CLL/SLL), testing for subtypes of the disease is becoming more important for prognosis and selection of the best treatment options.

October 18, 2021

CLL Society Ed Forum On Demand: The Right Tests at the Right Time – Session 5

Join CLL Society for this important Ed Forum to learn the basics about testing across the span of your CLL journey. At the time of diagnosis, find out which tests should be performed, which might be avoided, and why. Before starting your first treatment, and prior to every subsequent

August 27, 2021

Patient, Know Thyself

Patient, Know Thyself Mark Hoffman is a long-time CLL patient advocate and facilitator of the CLL Society Patient & Caregiver Support Group in San Diego, CA. In this article from Cancer Health, Mark echoes the importance of the Test Before Treat™ campaign by sharing his story. When Mark was

March 17, 2021

ASH 2020: Dr. Anthony Mato Discusses the Impact of del(17p) on Survival of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with First-Line Ibrutinib

ASH 2019: Dr. David Maloney on CAR-T therapy in CLL (chronic lymphocytic leukemia)

March 11, 2021

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Testing in Patients with Chronic Lymphocytic Leukemia (CLL)

At the American Society of Hematology’s (ASH) 2020 conference, there was research on looking at the genome of CLL and how different genetic markers might have predictive and value. Dr. Brian Koffman, Chief Medical Officer and Executive Vice President of CLL Society, interviewed Dr. Adrian Wiestner, a senior investigator at

February 6, 2021

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat Recorded Thursday, February 4, 2021 https://youtu.be/U9f7OCdcJcs Continue to Session 2: CLL Treatments: Chemotherapy, Immunotherapy, and Targeted Agents CLL Society Resources Download

January 29, 2021

iwCLL 2019: Dr. Nicole Lamanna on biomarker testing for chronic lymphocytic leukemia (CLL)

As the science of chronic lymphocytic leukemia has advanced, we have learned much more detailed information about its biology and the specific chromosomes, genes, and proteins that contribute to the disease. Checking for specific abnormalities in chromosomes and genetic variants can help doctors evaluate a patient’s prognosis and predict

January 25, 2021

ASH 2020: Dr. Anthony Mato on the Inform CLL (Chronic Lymphocytic Leukemia) Registry Test Before Treat™

This clinical trial introduces the concept of “synthetic lethality,” where multiple targeted agents are used at low dosages to block different pathways, and achieve the ability to kill cancer cells without the associated toxicities of using three drugs together at their usual dosages.

July 17, 2020

ASCO 2020 Top 12” #5: Survival trend of chronic lymphocytic leukemia and prognostic factors in the United States: An analysis of the National Cancer Database

ASCO 2020: Survival trend of chronic lymphocytic leukemia and prognostic factors in the United States: An analysis of the National Cancer Databas

CLL Testing & Imaging

Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: IGHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

CLL Society Ed Forum On Demand: The Right Tests at the Right Time – Session 5

Patient, Know Thyself

ASH 2020: Dr. Anthony Mato Discusses the Impact of del(17p) on Survival of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with First-Line Ibrutinib

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Testing in Patients with Chronic Lymphocytic Leukemia (CLL)

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat

iwCLL 2019: Dr. Nicole Lamanna on biomarker testing for chronic lymphocytic leukemia (CLL)

ASH 2020: Dr. Anthony Mato on the Inform CLL (Chronic Lymphocytic Leukemia) Registry Test Before Treat™

ASCO 2020 Top 12” #5: Survival trend of chronic lymphocytic leukemia and prognostic factors in the United States: An analysis of the National Cancer Database

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT